Replies to post #60785 on NorthWest Biotherapeutics Inc (NWBO)

[PacificNW]

This I can confidently say:
No matter how I think mgmt screwed up with their financing and with their main investor and with their decisions and choices I know one thing is for sure when they are able to release the good news that is about to come down any time now (the timing is obviously not under their control) it will easily have huge impact on the pps pushing it up to unknown heights.....it could happen tomorrow it could happen next week, who knows.....the tough part is the wait....I am confident of this crystal ball that is for sure.
Screw every lying shorter who has hurt NWBO (and me) with lies and innuendos....the truth is out there.

[Poor Man -]

Not wishful thinking at all.

Could that something be BMY and MRK taking a stake in NWBO and that negotiations are going behind the scene? This would provide the funding for the trials once for all. Last year Celgene injected 1 billion into JUNO so it's not entirely improbable.

Wishful thinking?

At this juncture, the stock price and the intrinsic value of the company are simply divorced. This is due to a combination of factors that have as much to do with the biotech sectors as it does with company specific events. And yes, there are also forces out to get the company that has exacerbated problems with the stock.

There's certainly a fair amount of business going on behind the scenes, especially if the company is close to closing some form of agreements with three Big Pharma companies. And not only does that provide a measure of validation of the science, but these biotech firms are probably not entering into those arrangement unless the trials are expected to be fully funded.

I'm advocating the Rip Van Winkle strategy with this stock: take a long nap and check back in a few months.

[doingmybest]

I do not think it is just wishful thinking at all. I have thought of the value of NWBO's science to either BMY or to MRK in a firesale, certainly much more than what NWBO is valued at today by the market. It appears NWBO is nearing a crossroads, and, has to get an infusion of significant information or cash or a combination. Obviously they prefer and may still be planning on information to break, which certainly has the potential to right the ship here. But, they need a plan B soon, as they are currently running far afoul of prudent financial mgmt. The financial pressure at that office must be unbearable until they go back and review their trial data and patient stories, which I am sure keeps them going. If they are now offering part of the future value of the company to a major partner, whether that be in the form of an ex-U.S. licensing deal, or, just a shared ownership, that may just be best at this point, because they appear to be too close to the edge.